Continuous transversus abdominis plane block in gastric cancer patients undergoing minimally invasive gastrectomy

Continuous transversus abdominis plane block in gastric cancer patients undergoing minimally invasive gastrectomy: a randomized-controlled trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0010352

Enrollment

Registered

2025-03-28

Start date

2025-04-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : This study compares three intervention groups for postoperative pain management in gastric cancer patients undergoing minimally invasive gastrectomy: 1. IV-PCA Alone Group 2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Adults aged 19 to under 85 years ? Patients diagnosed with gastric cancer who are scheduled to undergo the following minimally invasive gastrectomy procedures: A. Laparoscopic gastrectomy B. Robot-assisted gastrectomy ? Patients who have voluntarily consented to participate in the study

Exclusion criteria

Exclusion criteria: ? Cases where Ropivacaine administration is contraindicated: A. Hypersensitivity to amide-type local anesthetics, including Ropivacaine B. Massive bleeding or shock state C. Sepsis ? Body mass index (BMI) below 18 kg/m² ? High risk of procedure-related bleeding due to the use of anticoagulants or antiplatelet agents ? Patients diagnosed with liver cirrhosis ? Patients experiencing chronic pain or hyperalgesia ? Patients receiving opioid analgesics preoperatively ? Patients with a history of long-term systemic steroid use ? Patients deemed to have a high likelihood of conversion to open surgery ? Other cases where the investigator determines that study participation is inappropriate

Design outcomes

Primary

Measure	Time frame
Cumulative opioid consumption;Procedure-related complications;Local anesthetic-related adverse effects	—

Secondary

Measure	Time frame
Cumulative opioid consumption;Postoperative pain scores (NRS) during rest and movement;QoR-15 survey scores;Antiemetic use (ramosetron, metoclopramide);Patient satisfaction with postoperative pain control (7-point Likert scale)	—

Countries

Korea, Republic of

Contacts

Public ContactDongjae Jeon

Seoul National University Bundang Hospital

djj1011@naver.com+82-31-787-6573

Outcome results